Inclusive Quantification Assay of Serum Des‐γ‐Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry
Jihyeon Lee, Young‐Suk Lim, Jeong‐Hoon Lee, Geum‐Youn Gwak, Misol Do, Injoon Yeo, Dongyoon Shin, Dohyun Han, Taesung Park, Youngsoo Kim – 11 June 2021 – Hepatocellular carcinoma (HCC) is a malignant cancer with one of the highest mortality rates. Des‐γ‐carboxyprothrombin (DCP) is an HCC serologic surveillance marker that can complement the low sensitivity of alpha‐fetoprotein (AFP). DCP exists in the blood as a mixture of proteoforms from an impaired carboxylation process at glutamic acid (Glu) residues within the N‐terminal domain.